Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Proparacaine
Drug ID BADD_D01862
Description Proparacaine is a topical anesthetic drug of the amino ester group. It is found in ophthalmic solutions at a concentration of 0.5% as the hydrochloride salt.
Indications and Usage Used as a local (ophthalmic) anesthetic.
Marketing Status Prescription; Discontinued
ATC Code S01HA04
DrugBank ID DB00807
KEGG ID D08448
MeSH ID C005717
PubChem ID 4935
TTD Drug ID D0Q7ZG
NDC Product Code Not Available
Synonyms proxymetacaine | benzoic acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl ester | proparacaine | proxymethacaine | 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate | Alcaine | Chibro-Kerakain | Kainair | Kéracaine | proxymetacaine hydrochloride | proparacaine HCl | proxymetacaine monohydrochloride | benzoic acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl ester, monohydrochloride*benzoic acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl ester, monohydrochloride | proparacaine hydrochloride | 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate monohydrochloride | Ocu-Caine | Ophthaine | Ophthetic | Parcaine | Proparakain-POS | AK-Taine | Minims Proxymetacaine Hydrochloride
Chemical Information
Molecular Formula C16H26N2O3
CAS Registry Number 499-67-2
SMILES CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blepharospasm17.17.02.001; 06.05.01.0010.000732%Not Available
Corneal epithelium defect06.06.03.0120.001951%Not Available
Corneal erosion06.06.03.0030.000488%Not Available
Corneal infiltrates06.08.01.0020.002927%Not Available
Corneal oedema06.04.02.0010.003659%Not Available
Corneal opacity06.06.03.0050.001464%Not Available
Corneal perforation12.01.04.003; 06.06.03.0060.000488%Not Available
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Dizziness17.02.05.003; 24.06.02.007; 02.01.02.0040.000488%
Drug abuse19.07.02.0100.001336%Not Available
Eye pain06.08.03.0020.001951%
Eyelid oedema23.04.01.003; 10.01.05.001; 06.04.04.0040.000732%Not Available
Haemoglobin13.01.05.018--Not Available
Hypopyon11.01.06.009; 06.04.10.0040.003659%Not Available
Iritis10.02.01.022; 06.04.03.002--Not Available
Keratitis06.04.02.0020.000488%
Keratopathy06.06.03.0070.005366%Not Available
Lacrimation increased06.08.02.0040.000488%
Liver disorder09.01.08.001--Not Available
Loss of consciousness17.02.04.0040.000732%Not Available
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Necrosis24.04.02.006; 08.03.03.001--Not Available
Ocular hyperaemia06.04.05.0040.000488%Not Available
Pain08.01.08.004--
Photophobia06.01.01.004; 17.17.02.0060.001707%
Vision blurred17.17.01.010; 06.02.06.0070.000488%
Visual acuity reduced17.17.01.011; 06.02.03.0010.000732%
Conjunctival hyperaemia06.04.01.0040.002683%Not Available
Corneal thinning06.06.03.0090.000318%Not Available
Haemorrhage24.07.01.002--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages